Boehringer Ingelheim and WHO Foundation partner to enhance healthcare access and suicide prevention in the Americas, pledging $5M.

Boehringer Ingelheim and the WHO Foundation have announced a partnership to enhance healthcare access and suicide prevention, pledging $5 million. This initiative focuses on vulnerable populations in the Americas and supports the WHO's Fourteenth General Program of Work (2025-2028). The collaboration aims to fund evidence-based interventions, mobilize resources for mental health, and promote global financing for equitable healthcare services.

October 15, 2024
5 Articles

Further Reading